» Articles » PMID: 37189787

Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy

Overview
Journal Biomedicines
Date 2023 May 16
PMID 37189787
Authors
Affiliations
Soon will be listed here.
Abstract

The pathogenesis of hepatocellular carcinoma (HCC) is a multifactorial process that has not yet been fully investigated. Autophagy and apoptosis are two important cellular pathways that are critical for cell survival or death. The balance between apoptosis and autophagy regulates liver cell turnover and maintains intracellular homeostasis. However, the balance is often dysregulated in many cancers, including HCC. Autophagy and apoptosis pathways may be either independent or parallel or one may influence the other. Autophagy may either inhibit or promote apoptosis, thus regulating the fate of the liver cancer cells. In this review, a concise overview of the pathogenesis of HCC is presented, with emphasis on new developments, including the role of endoplasmic reticulum stress, the implication of microRNAs and the role of gut microbiota. The characteristics of HCC associated with a specific liver disease are also described and a brief description of autophagy and apoptosis is provided. The role of autophagy and apoptosis in the initiation, progress and metastatic potential is reviewed and the experimental evidence indicating an interplay between the two is extensively analyzed. The role of ferroptosis, a recently described specific pathway of regulated cell death, is presented. Finally, the potential therapeutic implications of autophagy and apoptosis in drug resistance are examined.

Citing Articles

Anticancer activity of Weizmannia coagulans MZY531on H22 tumor-bearing mice by regulating inflammation, autophagy-dependent apoptosis, and gut microbiota.

Liu C, Tan M, Zhao L, Gai M, Zhou T, Yu C Sci Rep. 2025; 15(1):8250.

PMID: 40065050 PMC: 11894224. DOI: 10.1038/s41598-025-92825-9.


Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights.

Rahdan F, Saberi A, Saraygord-Afshari N, Hadizadeh M, Fayeghi T, Ghanbari E Heliyon. 2024; 10(20):e39489.

PMID: 39498055 PMC: 11532857. DOI: 10.1016/j.heliyon.2024.e39489.


Liver cell cancer surveillance practice in Nigeria: Pitfalls and future prospects.

Musa Y, Ifeorah I, Maiyaki A, Almustapha R, Maisuna Y, Saleh H World J Hepatol. 2024; 16(10):1132-1141.

PMID: 39474579 PMC: 11514613. DOI: 10.4254/wjh.v16.i10.1132.


Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review).

Ye G, Ye M, Jin X Am J Cancer Res. 2024; 14(9):4113-4171.

PMID: 39417171 PMC: 11477829. DOI: 10.62347/UJVP4361.


Anticancer Activity of Delta-Tocotrienol in Human Hepatocarcinoma: Involvement of Autophagy Induction.

Montagnani Marelli M, Macchi C, Ruscica M, Sartori P, Moretti R Cancers (Basel). 2024; 16(15).

PMID: 39123382 PMC: 11311296. DOI: 10.3390/cancers16152654.


References
1.
Wong V, Chan W, Chitturi S, Chawla Y, Dan Y, Duseja A . Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment. J Gastroenterol Hepatol. 2017; 33(1):70-85. DOI: 10.1111/jgh.13857. View

2.
Lim L, Wong S, Huang F, Lim S, Chong S, Ooi L . Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Cancer Res. 2019; 79(20):5131-5139. DOI: 10.1158/0008-5472.CAN-19-0255. View

3.
Ding W, Ni H, Gao W, Hou Y, Melan M, Chen X . Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J Biol Chem. 2006; 282(7):4702-4710. DOI: 10.1074/jbc.M609267200. View

4.
Ganne-Carrie N, Nahon P . Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol. 2019; 70(2):284-293. DOI: 10.1016/j.jhep.2018.10.008. View

5.
Yang L, He J, Chen L, Wang G . Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells. Med Oncol. 2008; 26(4):445-51. DOI: 10.1007/s12032-008-9144-1. View